ReviewJournal of digestive diseases

Ripretinib for the treatment of advanced, imatinib-resistant gastrointestinal stromal tumors.

Wei Zhen Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.